With a promising cannabinoid pipeline, an alternative to the EpiPen, and a superior solution for opioid overdoses, this firm has moved in on not one but three of the hottest biotech segments. CLICK HERE.
![](https://stockinvestornews.com/wp-content/uploads/2023/04/money-ga3766759e_640-Pixabay.jpeg)
With a promising cannabinoid pipeline, an alternative to the EpiPen, and a superior solution for opioid overdoses, this firm has moved in on not one but three of the hottest biotech segments. CLICK HERE.